RE: Shocking "journalism"28 Aug 2020 13:33
Parsley, what I don’t understand is how theyy have misinterpreted what the company is doing. They have spent 15 years working on this drug for COPD patients! No mention of COPD!!! The drug had been successful at every step with stellar results in the phase 2 Covid trial. Attracted millions of pounds from Venrock, yet MF have tried to deramp 3 times this week, someone must be rattled it’s unheard of. The article is not balanced and forgets a lot of good points whilst focusing only on risk factors. It makes me feel like buying more tbh, there’s clearly something going on.